Meningioma classification by immunohistochemistry: A replicability study

INTRODUCTION: Meningiomas account for nearly 40% of intracranial tumors. Recently, the immunohistochemistry (IHC) markers S100B, SCGN, ACADL and MCM2 have been shown to be associated with underlying biological subtypes of meningioma (MG1-MG4). We aimed to evaluate these IHC markers in a clinical set...

Descripción completa

Detalles Bibliográficos
Autores principales: Näslund, Olivia, Lipatnikova, Anna, Dénes, Anna, Lindskog, Cecilia, Bontell, Thomas Olsson, Smits, Anja, Jakola, Asgeir S., Corell, Alba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845417/
https://www.ncbi.nlm.nih.gov/pubmed/36685704
http://dx.doi.org/10.1016/j.bas.2022.101711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845417/
https://www.ncbi.nlm.nih.gov/pubmed/36685704
http://dx.doi.org/10.1016/j.bas.2022.101711

Ejemplares similares